Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease
2007-003341-32Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2007
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Provacel in Acute Graft-Versus-Host Disease (aGvHD), sponsored by University Medical Center Utrecht. Primary endpoint: Response of acute graft-versus-host disease. Started Oct 2007; status: completed.
02
Drugs
Provacel
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on 2007-003341-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003341-32.